Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-30

Clinical Trial Update: Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of psilocybin-assisted therapy for cancer-related anxiety in patients with metastatic cancer has completed and results were posted. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of Washington | Conditions: Hematopoietic and Lymphatic System Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-30